The North America urinalysis market has experienced significant expansion over the past ten years and is set for ongoing growth from 2021 to 2031, propelled by advancements in diagnostic technology, a rising prevalence of chronic illnesses, and an increasing demand for preventive healthcare. Urinalysis, a widely used non-invasive diagnostic examination, is essential for the early identification and monitoring of various medical conditions such as urinary tract infections (UTIs), kidney ailments, liver issues, diabetes, and other metabolic disorders. As awareness around regular health check-ups and chronic disease screenings rises in the U. S. and Canada, urinalysis remains a primary diagnostic tool across clinical, homecare, and research environments. One main factor driving growth in the North American urinalysis market is the increasing incidence of chronic kidney disease (CKD), diabetes, and hypertension, all of which demand regular urinalysis for ongoing disease monitoring. According to the CDC, more than 37 million Americans are diagnosed with CKD, many of whom go undetected. This growing patient population is leading to heightened demand for swift and precise urinalysis. Furthermore, the expanding elderly demographic—who are more vulnerable to urinary tract and renal issues—is anticipated to further accelerate market growth. Another contributing factor is the rise in point-of-care testing and the broad availability of automated urinalysis systems that provide real-time data analysis, thereby improving diagnostic accuracy and efficiency.
North America urinalysis market is projected to grow by 6.3% annually in the forecast period and reach $1,973.2 million by 2031. Technological advancements have revolutionized the urinalysis landscape, especially with the incorporation of artificial intelligence, machine learning, and digital imaging within diagnostic instruments. These innovations have facilitated quicker and more dependable test outcomes, minimized manual inaccuracies, and optimized workflows for laboratories and hospitals. The uptake of automated urine analyzers equipped with integrated software systems for data management has also increased, particularly among larger diagnostic networks and hospitals. Additionally, the shift toward home-based health monitoring, accelerated by the COVID-19 crisis, has generated new prospects for portable urinalysis kits, particularly for chronic disease management. The U. S. leads the North American urinalysis market due to its well-established healthcare system, substantial healthcare spending, and a strong presence of major market players such as Siemens Healthineers, Beckman Coulter (a subsidiary of Danaher), Sysmex Corporation, and Roche Diagnostics. These firms are consistently investing in research and development to launch innovative urinalysis products that serve both clinical and home applications. Strategic partnerships with healthcare providers and government initiatives aimed at chronic disease screenings further bolster the market’s strong growth potential. Canada also shows a burgeoning market, underpinned by universal healthcare coverage and increased funding in laboratory diagnostics and public health initiatives.
What's Inside a Bonafide Research`s industry report?
A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.
The urinalysis market in North America is mainly propelled by two key nations—the United States and Canada—both of which significantly influence the regional framework through advancements in healthcare, infrastructure, and governmental assistance. The United States leads the market, holding the largest proportion because of its sophisticated medical technology environment, high rates of chronic illnesses, and extensive use of diagnostic testing. The U. S. hosts major industry figures such as Beckman Coulter, Siemens Healthineers, Abbott Laboratories, and Roche Diagnostics, who are consistently investing in research and development to create state-of-the-art automated urinalysis systems and consumables. The nation's well-established network of hospitals, diagnostic laboratories, and point-of-care units guarantees steady demand for urinalysis, especially for diabetes, kidney diseases, urinary tract infections (UTIs), and prenatal screening. Moreover, public health campaigns led by organizations such as the Centers for Disease Control and Prevention (CDC) and National Kidney Foundation emphasize the importance of early identification and observation of chronic conditions, which further enhances the need for urinalysis in various environments. The growth of home-based testing and telemedicine has also created new pathways for distributing urinalysis kits in remote and rural regions. Canada, although smaller in market size relative to the U. S. , is witnessing significant growth driven by universal healthcare coverage, a rising understanding of preventive diagnostics, and an aging population. Canadian healthcare facilities are increasingly utilizing more automated and AI-enhanced diagnostics to boost efficiency and results, particularly in underserved or rural areas. Both federal and provincial health initiatives have started to incorporate routine urinalysis more extensively into chronic disease management plans, especially concerning diabetes and kidney-related issues.
By Product Type, the North America urinalysis market is categorized into Instruments and Consumables. Within the instruments category, Automated Analyzers are predominant due to their efficacy, accuracy, and broad usage in high-throughput laboratories. Semi-automated Analyzers continue to be utilized in mid-sized practices, while Point-of-Care (PoC) Analyzers are increasingly preferred in clinics and domestic settings for immediate diagnosis. Regarding consumables, Reagents and Kits lead in revenue production, followed closely by Dipsticks, which are economical and commonly used for routine examinations. Disposables such as cups, gloves, and testing containers support the rising number of tests. This segment is experiencing ongoing expansion driven by a rise in testing frequency in both clinical and home environments. From 2021 to 2031, the demand for products is projected to increase consistently, especially for PoC devices and reagent kits, as decentralization and preventive diagnostics gain traction. By Test Type, the market is made up of Biochemical Tests, Pregnancy and Fertility Tests, and Sediment Tests. Biochemical testing commands the highest share, extensively employed for identifying glucose, ketones, protein, bilirubin, and various analytes that are crucial for diagnosing ailments such as diabetes, liver problems, and infections. Pregnancy and fertility tests remain widely utilized for both clinical and at-home applications, propelled by their convenience and reliability. Sediment tests, which necessitate microscopic analysis of urine for cells, crystals, and bacteria, are vital for diagnosing UTIs and kidney issues, particularly in hospital environments. Innovations in urinalysis automation are enhancing the efficiency of sediment analysis, broadening its application within healthcare facilities. Revenue from all test categories is anticipated to rise through 2031, with biochemical tests continuing to lead owing to their frequent application and integration into chronic disease management protocols throughout the area.
By Applications, the North America urinalysis market is divided into Pregnancy and Fertility, Urinary Tract Infections (UTI), Diabetes, Kidney Diseases, Liver Diseases, and Other Applications. UTI testing is a primary application due to its high occurrence, especially among women and the elderly. Diabetes monitoring through urinalysis significantly contributes as glucose and ketone detection is essential for both diagnosis and ongoing management of the condition. Pregnancy and fertility tests continue to enjoy strong consumer acceptance, particularly in homecare environments. Kidney and liver disease diagnostics utilize urinalysis for the early identification of organ dysfunction, while other applications encompass drug screenings, metabolic assessments, and general health evaluations. The rising prevalence of chronic diseases and increased health awareness are propelling greater adoption of urinalysis across all applications, with UTI and diabetes segments projected to show the most rapid growth through 2031. By End User, the market consists of Hospitals and Clinics, Diagnostic Laboratories, Home Care Settings, and Research Laboratories and Institutes. Hospitals and clinics lead due to their extensive patient base and integrated diagnostic services. These facilities carry out large quantities of urinalysis tests for disease identification and patient tracking. Diagnostic laboratories are a close second, preferred for their automation, high volume capacity, and specialized knowledge in sample handling. The home care segment is experiencing swift growth, driven by the need for convenient, self-administered tests for pregnancy, glucose, and UTI monitoring. At the same time, research laboratories and institutes utilize urinalysis for biomarker identification and drug creation. From 2021 to 2031, all segments are anticipated to expand, with home care settings showing the highest CAGR due to advancements in technology, increasing prevalence of chronic conditions, and the movement towards personalized, remote health monitoring.
Make this report your own
Have queries/questions regarding a report
Take advantage of intelligence tailored to your business objective
Sikandar Kesari
Research Analyst
Considered in this report
• Historic Year: 2019
• Base year: 2024
• Estimated year: 2025
• Forecast year: 2030
Aspects covered in this report
• North America Urinalysis North America Urinalysis Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation
Based on Product Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Instruments
• Automated Analyzer
• Semi-automated Analyzer
• Point-of-Care Analyzer
• Consumables
• Reagents & Kits
• Dipsticks
• Disposables
Don't pay for what you don't need. Save 30%
Customise your report by selecting specific countries or regions
Based on Test Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Biochemical Test
• Pregnancy & Fertility Test
• Sediment Test
By Applications, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Pregnancy & Fertility
• Urinary Tract Infections (UTI)
• Diabetes
• Kidney Diseases
• Liver Diseases
• Other Applications
By End User, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Hospitals and Clinics
• Diagnostic Laboratories
• Home Care Settings
• Research Laboratories & Institutes
The approach of the report:
This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and listing out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, annual report of companies, analyzing the government generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducted trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers in regional aspects, tier aspects, age group, and gender. Once we have primary data with us we have started verifying the details obtained from secondary sources.
Intended audience
This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to agriculture industry, government bodies and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.
Table of Contents
1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 13
1.2.6 Market Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16
2 Market Overview and Dynamics 18
2.1 Market Size and Forecast 18
2.1.1 Impact of COVID-19 on World Economy 19
2.1.2 Impact of COVID-19 on the Market 21
2.2 Major Growth Drivers 23
2.3 Market Restraints and Challenges 29
2.4 Emerging Opportunities and Market Trends 32
2.5 Porter’s Fiver Forces Analysis 36
3 Segmentation of North America Market by Product Type 40
3.1 Market Overview by Product Type 40
3.2 Instruments 42
3.2.1 Automated Analyzer 44
3.2.2 Semi-automated Analyzer 45
3.2.3 Point-of-Care Analyzer 46
3.3 Consumables 47
3.3.1 Reagents & Kits 48
3.3.2 Dipsticks 49
3.3.3 Disposables 50
4 Segmentation of North America Market by Test Type 51
4.1 Market Overview by Test Type 51
4.2 Biochemical Test 53
4.3 Pregnancy & Fertility Test 54
4.4 Sediment Test 55
5 Segmentation of North America Market by Application 56
5.1 Market Overview by Application 56
5.2 Pregnancy & Fertility 58
5.3 Urinary Tract Infections (UTI) 59
5.4 Diabetes 60
5.5 Kidney Diseases 61
5.6 Liver Diseases 62
5.7 Other Applications 63
6 Segmentation of North America Market by End User 64
6.1 Market Overview by End User 64
6.2 Hospitals and Clinics 66
6.3 Diagnostic Laboratories 67
6.4 Home Care Settings 68
6.5 Research Laboratories & Institutes 69
7 North America Market 2021-2031 by Country 70
7.1 Overview of North America Market 70
7.2 U.S. 73
7.3 Canada 76
7.4 Mexico 78
8 Competitive Landscape 80
8.1 Overview of Key Vendors 80
8.2 New Product Launch, Partnership, Investment, and M&A 83
8.3 Company Profiles 84
77 Elektronika Kft. 84
Abbott Laboratories 86
Acon Laboratories Inc. 87
Arkray Inc. 88
Becton, Dickinson and Company 89
Bio-Rad Laboratories Inc. 90
Cardinal Health Inc. 91
Danaher Corporation (Beckman Coulter Inc.) 92
Eiken Chemical Co., Ltd. 93
F Hoffmann-La Roche Ltd. 94
Mindray Medical International Limited 95
Quidel Corporation 96
Siemens Healthineers AG 97
Sysmex Corporation 98
RELATED REPORTS 99
List of Tables:
Table 1. Snapshot of North America Urinalysis Market in Balanced Perspective, 2021-2031 17
Table 2. World Economic Outlook, 2021-2031 20
Table 3. World Health Spending by Region, $ bn, 2013-2020 28
Table 4. Main Product Trends and Market Opportunities in North America Urinalysis Market 32
Table 5. North America Urinalysis Market by Product Type, 2021-2031, $ mn 40
Table 6. North America Urinalysis Market: Instruments by Type, 2021-2031, $ mn 42
Table 7. North America Urinalysis Market: Consumables by Type, 2021-2031, $ mn 47
Table 8. North America Urinalysis Market by Test Type, 2021-2031, $ mn 51
Table 9. North America Urinalysis Market by Application, 2021-2031, $ mn 56
Table 10. North America Urinalysis Market by End User, 2021-2031, $ mn 64
Table 11. North America Urinalysis Market by Country, 2021-2031, $ mn 71
Table 12. U.S. Urinalysis Market by Product Type, 2021-2031, $ mn 75
Table 13. U.S. Urinalysis Market by Test Type, 2021-2031, $ mn 75
Table 14. U.S. Urinalysis Market by End User, 2021-2031, $ mn 75
Table 15. Canada Urinalysis Market by Product Type, 2021-2031, $ mn 77
Table 16. Canada Urinalysis Market by Test Type, 2021-2031, $ mn 77
Table 17. Canada Urinalysis Market by End User, 2021-2031, $ mn 77
Table 18. Mexico Urinalysis Market by Product Type, 2021-2031, $ mn 79
Table 19. Mexico Urinalysis Market by Test Type, 2021-2031, $ mn 79
Table 20. Mexico Urinalysis Market by End User, 2021-2031, $ mn 79
Table 21. 77 Elektronika Kft.: Company Snapshot 84
Table 22. 77 Elektronika Kft.: Business Segmentation 85
Table 23. 77 Elektronika Kft.: Product Portfolio 85
List of Figures:
Figure 1. Research Method Flow Chart 11
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 14
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 16
Figure 4. North America Urinalysis Market, 2021-2031, $ mn 18
Figure 5. Impact of COVID-19 on Business 21
Figure 6. Primary Drivers and Impact Factors of North America Urinalysis Market 23
Figure 7. Leading Causes of Death in the World, 2000 and 2019, million 26
Figure 8. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 27
Figure 9. World Population 65 and Over, % of Total Population, 1950-2060 27
Figure 10. Primary Restraints and Impact Factors of North America Urinalysis Market 29
Figure 11. Investment Opportunity Analysis 33
Figure 12. Porter’s Fiver Forces Analysis of North America Urinalysis Market 36
Figure 13. Breakdown of North America Urinalysis Market by Product Type, 2021-2031, % of Revenue 41
Figure 14. North America Addressable Market Cap in 2022-2031 by Product Type, Value ($ mn) and Share (%) 41
Figure 15. North America Urinalysis Market by Product Type: Instruments, 2021-2031, $ mn 42
Figure 16. North America Urinalysis Market by Instruments: Automated Analyzer, 2021-2031, $ mn 44
Figure 17. North America Urinalysis Market by Instruments: Semi-automated Analyzer, 2021-2031, $ mn 45
Figure 18. North America Urinalysis Market by Instruments: Point-of-Care Analyzer, 2021-2031, $ mn 46
Figure 19. North America Urinalysis Market by Product Type: Consumables, 2021-2031, $ mn 47
Figure 20. North America Urinalysis Market by Consumables: Reagents & Kits, 2021-2031, $ mn 48
Figure 21. North America Urinalysis Market by Consumables: Dipsticks, 2021-2031, $ mn 49
Figure 22. North America Urinalysis Market by Consumables: Disposables, 2021-2031, $ mn 50
Figure 23. Breakdown of North America Urinalysis Market by Test Type, 2021-2031, % of Sales Revenue 52
Figure 24. North America Addressable Market Cap in 2022-2031 by Test Type, Value ($ mn) and Share (%) 52
Figure 25. North America Urinalysis Market by Test Type: Biochemical Test, 2021-2031, $ mn 53
Figure 26. North America Urinalysis Market by Test Type: Pregnancy & Fertility Test, 2021-2031, $ mn 54
Figure 27. North America Urinalysis Market by Test Type: Sediment Test, 2021-2031, $ mn 55
Figure 28. Breakdown of North America Urinalysis Market by Application, 2021-2031, % of Sales Revenue 57
Figure 29. North America Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%) 57
Figure 30. North America Urinalysis Market by Application: Pregnancy & Fertility, 2021-2031, $ mn 58
Figure 31. North America Urinalysis Market by Application: Urinary Tract Infections (UTI), 2021-2031, $ mn 59
Figure 32. North America Urinalysis Market by Application: Diabetes, 2021-2031, $ mn 60
Figure 33. North America Urinalysis Market by Application: Kidney Diseases, 2021-2031, $ mn 61
Figure 34. North America Urinalysis Market by Application: Liver Diseases, 2021-2031, $ mn 62
Figure 35. North America Urinalysis Market by Application: Other Applications, 2021-2031, $ mn 63
Figure 36. Breakdown of North America Urinalysis Market by End User, 2021-2031, % of Revenue 65
Figure 37. North America Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%) 65
Figure 38. North America Urinalysis Market by End User: Hospitals and Clinics, 2021-2031, $ mn 66
Figure 39. North America Urinalysis Market by End User: Diagnostic Laboratories, 2021-2031, $ mn 67
Figure 40. North America Urinalysis Market by End User: Home Care Settings, 2021-2031, $ mn 68
Figure 41. North America Urinalysis Market by End User: Research Laboratories & Institutes, 2021-2031, $ mn 69
Figure 42. Breakdown of North America Urinalysis Market by Country, 2021 and 2031, % of Revenue 71
Figure 43. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 72
Figure 44. U.S. Urinalysis Market, 2021-2031, $ mn 74
Figure 45. Canada Urinalysis Market, 2021-2031, $ mn 76
Figure 46. Urinalysis Market in Mexico, 2021-2031, $ mn 78
Figure 47. Growth Stage of North America Urinalysis Industry over the Forecast Period 80
Market Research FAQs
The report uses 2019 as the historic year, 2024 as the base year, 2025 as the estimated year, with forecasts up to 2030.
One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. License information
One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. License information
Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. License information
All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). License information